iSAM Funds (UK)’s ANI Pharmaceuticals ANIP Stock Holding History

iSAM Funds (UK)’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,948	Closed	-$258K	–	615
2025 Q2	$258K	Buy	+3,948	New	+$257K	0.06%	383

Other funds holding ANIP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

iSAM Funds (UK)'s ANIP Position: Q3 2025 in Review

iSAM Funds (UK) sold out of ANI Pharmaceuticals (ANIP) in Q3 2025, closing a stake of 3,948 shares — an estimated $258K sold.

iSAM Funds (UK) first reported a position in ANIP in Q2 2025 and held it in 1 quarter. The position peaked at $258K in Q2 2025. 269 funds tracked by Wall St. Rank hold ANIP as of Q3 2025.

iSAM Funds (UK) reported no remaining ANI Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
iSAM Funds (UK) sold 3,948 ANI Pharmaceuticals shares in Q3 2025, an estimated $258K.
iSAM Funds (UK) first reported a position in ANI Pharmaceuticals in Q2 2025 and held it in 1 quarter.
iSAM Funds (UK)'s ANI Pharmaceuticals position peaked at $258K in Q2 2025.
269 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2025.

Based on iSAM Funds (UK)'s 13F filing for Q3 2025, filed 14 Nov 2025.